INTERNATIONAL SCIENTIFIC ASSOCIATI… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2002

Legal Domicile

Principal Officer

MARIA MARCO PHD

Phone

2793452650

Tax Period

2024-01-01 to 2024-12-31

INTERNATIONAL SCIENTIFIC ASSOCIATION FOR PROBIOTICS AND PREBIOTICS, founded in 2002, is a small nonprofit in the Science & Technology sector that reported $827K in total revenue in fiscal year 2024. The organization ran a surplus of $309K, a strong 37% operating margin.

Mission

To engender & disseminate information on high quality, multidisciplinary, scientific investigation in the fields of probiotics & prebiotics, & advance the development of scientific research in the fields of health promoting probiotics, prebiotics and related substances worldwide.

Program Service Accomplishments

Program 1

Expenses: $216,398 Revenue: $27,195

HOSTED AND/OR PARTICIPATED IN VARIOUS CONFERENCES THROUGHOUT THE WORLD INCLUDING THE ORGANIZATION'S 22ND MEETING HELD IN CORK, IRELAND IN 2024.

Program 2

Expenses: $41,698

ISAPP continues to focus on its core values of stewardship, advancing the science, and education. ISAPP strives to advance and recognize excellence in science in the biotics field by being a trusted authority, developing and promoting science-based communications, including various published articles, fostering scientific collaborations and educating about evidence-based use of biotics.

Program 3

Expenses: $25,948

Graduate students and post-doctoral fellows from around the world are encouraged to participate in advancing the science of probiotics, prebiotics, and fermented foods through the ISAPP Students and Fellows Association (SFA). The group offers professional development and networking as students and fellows prepare for a career in probiotic and prebiotic science, either in academia or industry.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $693,210

Investment Income $134,049

Other Revenue $0

TOTAL REVENUE $827,259

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $284,044

Other Expenses $517,985

TOTAL EXPENSES $517,985

Year-over-Year Comparison

	2024	2023	Change
Revenue	$827,259	$806,530	+0.0%
Expenses	$517,985	$720,619	-0.3%
Net Income	$309,274	$85,911	+2.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MARLA CUNNINGHAM	Executive Dir.	35.00	Officer Director	$0	$0	$0
KRISTIN VERBEKE PHARM PHD	Director	1.00	Director	$0	$0	$0
GABRIEL VINDEROLA PHD	Director	1.00	Director	$0	$0	$0
DANIEL MERENSTEIN MD	Director	1.00	Director	$0	$0	$0
ANISHA WIJEYESEKERA PHD	Secretary	2.00	Officer Director	$0	$0	$0
KAREN SCOTT PHD	Director	1.00	Director	$0	$0	$0
EAMONN QUIGLEY MD	Director	1.00	Director	$0	$0	$0
MARIA MARCO PHD	President	4.00	Officer Director	$0	$0	$0
SARAH LEBEER PHD	Vice President	2.00	Officer Director	$0	$0	$0
SEPPO SALMINEN PHD	Director	1.00	Director	$0	$0	$0
GEOFFREY PREIDIS MD PHD	Director	1.00	Director	$0	$0	$0
HANIA SZAJEWSKA PHD	Director	1.00	Director	$0	$0	$0
DANIEL J TANCREDI PHD	Director	1.00	Director	$0	$0	$0
KELLY SWANSON PHD	Treasurer	2.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$827,259	$517,985	$2,714,425	$309,274
2023	$806,530	$720,619	$2,510,903	$85,911
2022	$358,083	$235,040	$1,872,367	$123,043
2021	$522,696	$288,526	$1,623,968	$234,170
2020	$386,478	$176,918	$1,340,943	$209,560
2019	$395,243	$344,277	$1,105,563	$50,966
2018	$431,977	$233,753	$1,035,117	$198,224

INTERNATIONAL SCIENTIFIC ASSOCIATION FOR PROBIOTICS AND PREBIOTICS